Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Differential Sox10 genomic occupancy in myelinating glia.
Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.
Meta-analysis of associations between MTHFR and GST polymorphisms and susceptibility to multiple sclerosis.
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D3-Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation.
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county.
Oligodendrocyte plasticity with an intact cell body in vitro.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction.
Multiple sclerosis is primarily a neurodegenerative disease.
Blood Plasma Levels of Microelements in Patients with History of Optic Neuritis.
Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.
New immunological approaches in treating and diagnosing CNS diseases.
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis.
Health status, work impediments, and coping related to work roles of women with multiple sclerosis.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study.
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
Acute inflammatory myelopathies.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »